Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence.

[1]  P. Rothwell,et al.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.

[2]  C. la Vecchia,et al.  Aspirin use and pancreatic cancer risk , 2010, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[3]  L. Murray,et al.  Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case–control study , 2010, British Journal of Cancer.

[4]  M. Hebrok,et al.  Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. , 2010, The Journal of clinical investigation.

[5]  S. Seino,et al.  Mature acinar cells are refractory to carcinoma development by targeted activation of Ras oncogene in adult rats , 2010, Cancer science.

[6]  Gerald C. Chu,et al.  Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. , 2009, Cancer cell.

[7]  R. Hruban,et al.  Molecular classification of neoplasms of the pancreas. , 2009, Human pathology.

[8]  G. Feldmann,et al.  Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice , 2008, Proceedings of the National Academy of Sciences.

[9]  J. L. Goodman,et al.  Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia , 2008, Proceedings of the National Academy of Sciences.

[10]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[11]  G. Feldmann,et al.  Hedgehog signaling is required for effective regeneration of exocrine pancreas. , 2008, Gastroenterology.

[12]  H. Baba,et al.  Expression patterns of epiplakin1 in pancreas, pancreatic cancer and regenerating pancreas , 2008, Genes to cells : devoted to molecular & cellular mechanisms.

[13]  M. Barbacid,et al.  Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. , 2007, Cancer cell.

[14]  R. Kist,et al.  SOX9 is required for maintenance of the pancreatic progenitor cell pool , 2007, Proceedings of the National Academy of Sciences.

[15]  Gerald C. Chu,et al.  Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. , 2006, Genes & development.

[16]  H. Moses,et al.  Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. , 2006, Genes & development.

[17]  M. Hebrok,et al.  Hedgehog/Ras interactions regulate early stages of pancreatic cancer. , 2006, Genes & development.

[18]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[19]  R. Hruban,et al.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.

[20]  E. Cameron,et al.  Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. , 2005, Gastroenterology.

[21]  R. DePinho,et al.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.

[22]  E. Petricoin,et al.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.

[23]  P. Ruszniewski,et al.  Risk of pancreatic adenocarcinoma in chronic pancreatitis , 2002, Gut.

[24]  A. Berns,et al.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer , 2001, Nature Genetics.

[25]  A. Berns,et al.  Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice , 2001, Nature.

[26]  G. Klöppel,et al.  The K‐ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium , 1999, Cancer.

[27]  C. Foster,et al.  Proliferation of parenchymal epithelial cells enhanced in chronic pancreatitis , 1998, The Journal of pathology.

[28]  T. Tosteson,et al.  K-ras mutation in focal proliferative lesions of human pancreas. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  William L. Smith,et al.  Pharmacology of Prostaglandin Endoperoxide Synthase Isozymes‐1 and‐2 a , 1994, Annals of the New York Academy of Sciences.

[30]  J K McLaughlin,et al.  Pancreatitis and the risk of pancreatic cancer. , 1993, The New England journal of medicine.

[31]  E. Diamandis,et al.  Pancreatic cancer. , 2013, Clinical chemistry.

[32]  M. Serrano,et al.  Senescence in tumours: evidence from mice and humans , 2010, Nature Reviews Cancer.

[33]  D. Jaffe.  In Vivo Lineage Tracing Defines the Role of Acinar-to-Ductal Transdifferentiation in Inflammatory Ductal Metaplasia , 2008 .

[34]  E. Furth,et al.  Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. , 2006, Cancer research.

[35]  M. Löhr,et al.  Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. , 2005, Neoplasia.

[36]  D. Bar-Sagi,et al.  Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between , 2005, Cell Research.